Alethios Launches AI Platform to Simplify Human Health Research

October 21, 2025
Alethios has launched a software platform designed to make structured, outcomes-based human health research more accessible. The platform includes tools for study design, recruitment, and management, using generative AI to streamline processes that traditionally take months.

Alethios has officially launched its software platform aimed at making structured human health research accessible to a broader range of users, announced in a press release. The platform enables researchers—from biotech companies to citizen scientists—to design and execute studies using integrated data sources including self-reported outcomes, wearable sensors, and at-home biomarker kits.

Founded in 2023 by CEO Zeenia Framroze, Alethios offers two main tools: the Study Planner and Study Operator. The Study Planner allows users to design decentralized studies, digitize existing protocols, and generate recruitment materials in minutes using a generative AI feature called AI QuickStart. The Study Operator automates study logistics, participant management, and reporting through the Alethiad Participant Community.

Researchers can begin with a seven-day free trial and then continue using the platform for $100 per month. According to the company, studies built with Alethios have achieved participant adherence rates above 90% and reduced recruitment timelines to as little as three to four weeks.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

09/10
Rising Medical Solutions Launches Ask Leah for Claims Analysis
09/10
NYU Langone AI Uses Multiple 3D Mammograms to Predict Breast Cancer Risk
09/10
Insilico Medicine Begins Phase III Rentosertib Trial in China
09/09
iFlex Adds Kinotek 3D Movement Assessments at Stretch Studios
09/09
OnPoint AR Spine System Records 1.1 mm Error in Cadaver Study

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You May Also Like